Skip to main content
. Author manuscript; available in PMC: 2012 Mar 16.
Published in final edited form as: Thorax. 2010 Oct;65(10):870–877. doi: 10.1136/thx.2010.136317

Figure 2.

Figure 2

Figure 2

Figure 2

No differences were observed in geometric means of inflammatory (tumor necrosis factor [TNF], interleukin (IL)-6, and IL-10 shown in Panel A), coagulation (Factor IX, antithrombin, and thrombin-antithrombin [TAT) complexes shown in Panel B), and fibrinolysis (plasminogen activator [PAI]-1 and D-dimer shown in Panel C) biomarkers in 1427, 734, and 734 subjects with and without diabetes, respectively. Biomarkers were measured on presentation to the emergency department and over the first week of hospitalization and p values are shown for these comparisons.